• Wells Fargo has set a price target of $301 for Amazon (NASDAQ:AMZN), indicating a potential increase of about 21.7%.
• Amazon-backed Anthropic launches Claude for Healthcare, challenging OpenAI's ChatGPT Health and marking Amazon's deeper dive into healthcare through AI.
• The company's market capitalization stands at approximately $2.64 trillion, with recent stock performance showing a slight increase of 0.43%.

Amazon.com, Inc. (NASDAQ:AMZN) is a global leader in e-commerce and cloud computing. The company is known for its vast product offerings and services, including Amazon Web Services (AWS), which is a major player in the cloud industry. Amazon competes with companies like Microsoft and Google in cloud services and with retailers like Walmart in e-commerce.

On January 12, 2026, Wells Fargo set a price target of $301 for Amazon, suggesting a potential increase of about 21.7% from its current price of $247.34. This optimistic outlook comes as Amazon continues to expand its reach into new sectors, such as healthcare, through innovative AI tools.

Amazon-backed Anthropic recently launched Claude for Healthcare, a suite of AI tools designed to assist in medical environments. This move challenges OpenAI's ChatGPT Health and underscores Amazon's commitment to AI. Claude for Healthcare helps streamline tasks like processing claims and coordinating care, integrating with key medical databases for efficiency.

The stock's recent trading activity shows a slight increase of 0.43%, with a daily range between $242.25 and $247.86. Over the past year, Amazon's stock has fluctuated between a high of $258.60 and a low of $161.38. The company's market capitalization is approximately $2.64 trillion, reflecting its significant market presence.

Amazon's investment in AI, particularly in healthcare, could drive future growth and impact its stock performance. By enabling personalized insights and efficient data access, Amazon aims to enhance healthcare delivery, potentially influencing its valuation and market position.